Previous 10 | Next 10 |
Image source: The Motley Fool. Volition Rx Limited (NYSEMKT: VNRX) Q1 2021 Earnings Call May 12, 2021 , 8:00 a.m. ET Operator Continue reading For further details see: Volition Rx Limited (VNRX) Q1 2021 Earnings Call Transcript
VolitionRx Limited (VNRX) Q1 2021 Results Conference Call May 12, 2021 08:00 AM ET Company Participants Scott Powell - Executive Vice President of Investor Relations Cameron Reynolds - President and Chief Executive Officer Terig Hughes - Chief Financial Officer Conference Call Participants Ky...
VolitionRX (VNRX): Q1 GAAP EPS of -$0.12 in-line.Revenue of $25.53K beats by $0.02M vs. $544K year ago.Press Release For further details see: VolitionRX EPS in-line, beats on revenue
VolitionRx Limited Announces First Quarter 2021 Financial Results and Business Update Conference call to discuss financial and operational results scheduled for Wednesday, May 12, at 8:00 a.m. U.S. Eastern Time PR Newswire Secured strongest-ever balance sheet with ...
VolitionRx Limited Schedules First Quarter 2021 Earnings Conference Call and Business Update Conference call to take place Wednesday, May 12, 2021 at 8:00 am Eastern time PR Newswire AUSTIN, Texas , May 6, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICA...
LOS ANGELES, CA / ACCESSWIRE / April 19, 2021 / The Planet MicroCap Showcase will take place on April 20-22, 2021, where 66 SmallCap, MicroCap and NanoCap public and private companies will be presenting via virtual webcast to a global investor audience. The Planet MicroCap Showcase: VIRTU...
VolitionRx Limited Announces Publication of Significant Nu.Q® Capture Mass Spectrometry Paper PR Newswire AUSTIN, Texas , March 31, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing si...
The following slide deck was published by VolitionRx Limited in conjunction with this event. For further details see: VolitionRX (VNRX) Presents At Virtual Spring Investor Conference - Slideshow
VolitionRx Limited Appoints Dr. Tom Butera DVM as Chief Executive Officer for Volition Veterinary Subsidiary PR Newswire AUSTIN, Texas , March 30, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company dev...
VolitionRx Limited Appoints Two New Directors PR Newswire AUSTIN, Texas , March 29, 2021 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company developing simple, easy to use, cost effective blood tests to help...
News, Short Squeeze, Breakout and More Instantly...
VolitionRx Limited (NYSE American: VNRX) , a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, announced the engagement of PharmaVentures Ltd (“PharmaVentures”) to act as an advisor. PharmaVentures w...
Volition appoints PharmaVentures for Capture PCR™ and oncology portfolio licensing PR Newswire HENDERSON, Nev. , July 9, 2024 /PRNewswire/ -- VolitionRx Limited (NYSE AMERICAN: VNRX) ("Volition"), a multi-national epigenetics company, has appointed PharmaV...
VolitionRx Limited (NYSE American: VNRX) (“Volition”), a multi-national epigenetics company focused on saving lives and improving outcomes for people and animals with life-altering diseases, has released a mid-year review that highlights significant milestones, such as the expansio...